Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BMY | VRTX | GSK | ||
| Company | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gsk Plc ADR | ||
| Price Information | |||||
| Exchange | NYSE | NASDAQ | NYSE | ||
| Open | 54.98 | 465.23 | 48.74 | ||
| High | 55.18 | 470.34 | 49.16 | ||
| Low | 54.23 | 462.73 | 48.57 | ||
| Latest | 54.65 | 468.41 | 49.15 | ||
| Change | -0.29 | +1.06 | +0.50 | ||
| % Change | -0.53% | +0.23% | +1.03% | ||
| Volume | 9,701,718 | 1,330,000 | 5,430,027 | ||
| 20-Day Average Volume | 12,005,615 | 1,315,005 | 4,227,795 | ||
| Previous Close | 54.94 | 467.35 | 48.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 55.00 | 458.19 | 49.39 | ||
| 20-Day Raw Stochastic | 52.01% | 67.34% | 39.84% | ||
| 20-Day Relative Strength | 55.71 | 57.56 | 52.71 | ||
| Weighted Alpha | +0.82 | +9.92 | +44.07 | ||
| Today's Opinion | 80% Buy | 80% Buy | 72% Buy | ||
| Previous Opinion | 80% Buy | 80% Buy | 72% Buy | ||
| Last Month's Opinion | 72% Buy | 72% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.48% since 01/15/26 | +6.72% since 01/15/26 | +0.06% since 01/15/26 | ||
| Low | 53.54 on 01/21/26 | 429.00 on 01/20/26 | 47.62 on 01/20/26 | ||
| High | 56.56 on 01/16/26 | 472.58 on 01/22/26 | 49.16 on 01/23/26 | ||
| 1-Month | |||||
| %Chg | +0.68% since 12/23/25 | +2.00% since 12/23/25 | +0.61% since 12/23/25 | ||
| Low | 52.06 on 01/05/26 | 429.00 on 01/20/26 | 47.62 on 01/20/26 | ||
| High | 57.04 on 01/14/26 | 487.52 on 01/07/26 | 51.46 on 01/06/26 | ||
| 3-Month | |||||
| %Chg | +24.69% since 10/23/25 | +10.83% since 10/23/25 | +7.93% since 10/23/25 | ||
| Low | 42.52 on 10/29/25 | 403.16 on 11/04/25 | 42.85 on 10/24/25 | ||
| High | 57.04 on 01/14/26 | 487.52 on 01/07/26 | 51.46 on 01/06/26 | ||
| 6-Month | |||||
| %Chg | +11.58% since 07/23/25 | -1.79% since 07/23/25 | +29.24% since 07/23/25 | ||
| Low | 42.52 on 10/29/25 | 362.50 on 08/11/25 | 36.75 on 08/06/25 | ||
| High | 57.04 on 01/14/26 | 487.52 on 01/07/26 | 51.46 on 01/06/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 111,844,272 | 118,575,568 | 99,168,464 | ||
| Shares Outstanding, K | 2,035,753 | 253,719 | 2,038,406 | ||
| Annual Sales | 48,300,000,000 | 11,020,100,000 | 40,095,390,000 | ||
| Annual Net Income | -8,948,000,000 | -535,600,000 | 3,290,590,000 | ||
| Last Quarter Sales | 12,222,000,000 | 3,076,400,000 | 11,520,500,000 | ||
| Last Quarter Net Income | 2,201,000,000 | 1,082,900,000 | 2,713,320,000 | ||
| 60-Month Beta | 0.29 | 0.31 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.63 on 10/30/25 | 4.80 on 11/03/25 | 1.48 on 10/29/25 | ||
| Latest Earnings Date | 02/05/26 | 02/12/26 | 02/04/26 | ||
| Most Recent Dividend | 0.630 on 01/02/26 | N/A | 0.426 on 11/14/25 | ||
| Next Ex-Dividends Date | 01/02/26 | N/A | 11/14/25 | ||
| Ratios | |||||
| Price/Earnings ttm | 8.31 | 30.12 | 10.85 | ||